LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
LLY
745.48
-1.34%↓
JNJ
153.61
+0.7%↑
UNH
321.58
+1.9%↑
ABBV
184.82
-0.47%↓
NVO
68.12
+1.76%↑
24h
Current
Min
4.89
Max
5.22
Income | 1.3M -31M |
---|---|
Sales | -8.2M 31M |
EPS | -0.24 |
Profit margin | -100.779 |
Employees | 279 |
EBITDA | 972K -20M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +593.36% upside |
Market Cap | 53M |
---|---|
Previous open | 4.07 |
Previous close | 5.07 |
By Acuity
50%
50%
179 / 382 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
5.9501 / 7.66 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
20 maj 2025, 20:54 UTC
PNC to Buy Private-Equity Agent Aqueduct Capital
DJ
Read
20 maj 2025, 20:50 UTC
Palo Alto Networks Posts Higher 3Q Sales, Profit Slips
DJ
Read
20 maj 2025, 23:48 UTC
Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update
DJ
Read
20 maj 2025, 23:42 UTC
Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk
DJ
Read
20 maj 2025, 23:39 UTC
Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk
DJ
Read
20 maj 2025, 23:08 UTC
James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk
DJ
Read
20 maj 2025, 22:46 UTC
Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval
DJ
Read
20 maj 2025, 22:45 UTC
Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields
DJ
Read
20 maj 2025, 22:20 UTC
In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ
DJ
Read
20 maj 2025, 22:00 UTC
ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO
DJ
Read
20 maj 2025, 22:00 UTC
ZTO Express (Cayman) 1Q EPS 34c >ZTO
DJ
Read
20 maj 2025, 22:00 UTC
ZTO Express (Cayman) 1Q Rev $1.5B >ZTO
DJ
Read
20 maj 2025, 21:44 UTC
James Hardie Industries 4Q Adj EPS 36c >JHX
DJ
Read
20 maj 2025, 21:44 UTC
James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX
DJ
Read
20 maj 2025, 21:44 UTC
James Hardie Industries 4Q EPS 10c >JHX
DJ
Read
20 maj 2025, 21:44 UTC
James Hardie Industries 4Q Sales $972M >JHX
DJ
Read
20 maj 2025, 20:52 UTC
Elon Musk to Cut Back Political Spending -- 3rd Update
DJ
Read
20 maj 2025, 20:52 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
20 maj 2025, 20:52 UTC
Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk
DJ
Read
20 maj 2025, 20:30 UTC
PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC
DJ
Read
20 maj 2025, 20:28 UTC
PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC
DJ
Read
20 maj 2025, 20:23 UTC
Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks
DJ
Read
20 maj 2025, 20:22 UTC
XP 1Q Adj EPS BRL2.29 >XP
DJ
Read
20 maj 2025, 20:22 UTC
XP 1Q Rev BRL4.345B >XP
DJ
Read
20 maj 2025, 20:21 UTC
Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'
DJ
Read
20 maj 2025, 20:20 UTC
Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com
DJ
Read
20 maj 2025, 20:19 UTC
Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI
DJ
Read
20 maj 2025, 20:11 UTC
Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update
DJ
Read
20 maj 2025, 20:09 UTC
Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW
DJ
Read
20 maj 2025, 20:08 UTC
Palo Alto Networks Sees FY25 Adj EPS $3.26-Adj EPS $3.28 >PANW
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 35.5 USD 593.36%
High 105 USD
Low 8 USD
Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
6 ratings
5
Buy
1
Hold
0
Sell
Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Strong Bearish Evidence
All events are bearish.
Long Term
No Evidence
There are no events.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$